Singapore, March 10 -- Italy-based Tethis S.p.A., a pioneer in standardised liquid biopsy platform development, and Sheba Medical Center,Israel'slargest medical center, have announced a research collaboration to evaluate circulating tumour cells (CTCs) in rectal cancer patients using Tethis' proprietary technology. Under the agreement, a Tethis' See.dinstrument will be installed at Sheba's Institute of Pathology.

The study, led by Prof.Iris Barshackwill focus on monitoring CTCs and ctDNA in patients with rectal cancer before and after neoadjuvant therapy. Blood samples will be collected at multiple time points to establish baseline CTC levels and track changes throughout treatment.

The research aims to evaluate the potential of CTCs com...